Joseph Tacopina, attorney of former President Donald Trump, told The Epoch Times that the former president is planning to appeal the verdict that found him liable for battery and defamation charges in the E. Jean Carroll trial.
It came as a Manhattan grand jury on Tuesday ruled against former President Donald Trump on one count of defamation and one count of battery in a civil case launched against him by advice columnist E Jean Carroll. Both are civil charges that do not result in jail time.
The jury found that Trump should pay a total of about $5 million in damages to Carroll, including about $3 million for the defamation charge and about $2 million for the civil battery charge.
Judge Lewis Kaplan, a Clinton appointee who oversaw the trial, announced the verdict after a 9-member jury panel deliberated on the case’s merit for less than three hours.
It concluded a one-week-long civil trial in the Southern District Court of New York, in which Carroll, 79, claims Trump, 76, raped her in a dressing room at the Bergdorf Goodman department store in Manhattan in 1995 or 1996—committing a battery offense—and, in his denial of the incident, committed libel, a type of defamation in written words.
Trump’s denial of the incident, Carroll’s attorney alleged during the trial, hurt Carroll’s career prospects as a journalist and a writer.
At the time of the alleged offense, she did not report the incident to authorities for fear of backlash from Trump and his supporters, Carroll said during the trial. Tacopina, however, said during closing arguments that the reason Carroll didn’t call the police was that the allegation “would never make it through a police investigation in a million years.”
Carroll’s lawsuit traces back to 2019 when the writer accused then-President Trump of sexually assaulting her in the mid-1990s. After Trump denied Carroll’s allegations in 2019—saying that “she’s not my type”—Carroll filed a lawsuit accusing Trump of defaming her in the same year, citing those words. That lawsuit bounced around state, federal, and appellate courts in New York and Washington, D.C., without material consequences.
In 2022, the New York state legislature passed the Adult Survivor Act, which amended state law to give victims of certain sexual offenses a one-year window, beginning on Nov. 24, 2023, to file a civil lawsuit against alleged offenders. Carroll filed a second lawsuit on Nov. 24, 2022, under this Act, which went to trial and resulted in Tuesday’s verdict.
Trump has, until the present day, denied all of Carroll’s allegations.
“Waiting for a jury decision on a False Accusation where I, despite being a current political candidate and leading all others in both parties, am not allowed to speak or defend myself, even as hard nosed reporters scream questions about this case at me,” Trump wrote on Truth Social on Tuesday.
“In the meantime, the other side has a book falsely accusing me of Rape, & is working with the press,” the former president wrote, referring to Carroll’s book “What Do We Need Men For?” that included her allegations regarding the incident.
“I will therefore not speak until after the trial, but will appeal the Unconstitutional silencing of me, as a candidate, no matter the outcome!” Trump wrote.
Key Question: Credibility
A central question to the case is whether Carroll’s claim that Trump had sexually assaulted her is credible.
Carroll testified during the trial regarding the alleged incident. Carroll’s attorney, Roberta Kaplan (unrelated to the judge), said that Carroll’s testimony during the trial was credible, and that “every single aspect of what she said is backed up or corroborated by other evidence.”
The testimony by two other women at trial, who also alleged that Trump sexually assaulted them, established a pattern of misconduct, Roberta Kaplan said. Trump has denied those allegations.
But Tacopina disagreed. He said that Carroll could not recall key details of the alleged offense, and that makes her story “unbelievable.”
“Now she claims she didn’t say the day of the week because she wasn’t 100 percent certain. She tailored her testimony right in front of you, right in front of you,” Tacopina said during the closing argument. “We know reality from fiction.”
Don’t wait for a stock market crash, dedollarization, or CBDCs before securing your retirement with physical precious metals. Genesis Gold Group can help.
A key moment in the trial was when a video of Trump’s deposition was played, whereby the former president was asked about the “Access Hollywood” tape that featured his words: “when you’re a star, they let you do it. You can do anything.”
Carroll’s attorney argued during the trial that these statements showed Trump’s attitude toward sexually assaulting women.
“What is Donald Trump doing here? Telling you in his very own words how he treats women,” Kaplan said. “It’s his modus operandi, M.O.” Or as Ferrara put it: “It was a confession.”
But Tacopina disagreed, saying that Trump’s words do not play into Carroll’s credibility and the case’s merit.
“It’s crude. It’s rude,” Tacopina said. said. “I’d knock my boy’s teeth out if he talked like that, honestly.”
“But that doesn’t make Ms. Carroll’s unbelievable story believable.”
During the closing argument on Monday, Tacopina doubled down on his statement that Carroll’s case was motivated by political reasons, a claim that Carroll’s attorneys denied.
“What E. Jean Carroll has done here is an affront to justice. She has abused this system by bringing a false claim for amongst other things money, status, political reasons,” Tacopina said.
Legal Expert Weighs In
Alan Dershowitz, a professor who taught at Harvard Law School for 50 years, told The Epoch Times on May 8 that he believes that Carroll’s case fails based on procedural considerations alone.
“Those cases never should have been allowed to be brought,” Dershowitz told EpochTV’s American Thought Leaders program in an interview, referring to the two cases Carroll brought against Trump.
“The historical purpose of a statute of limitations is to make sure you don’t have to stand trial for something that occurred 25 years ago—in this case, even more than that,” he explained. “How do you remember things? How do you know where you were? Maybe he was in Europe at the time. She hasn’t even given the dates and the times of the year.”
“It’s a case that normally would be thrown out—but again, it’s Donald Trump,” Dershowitz said.
Subscribe for free to the America First Report newsletter.
The scholar said he believes that Carroll’s case, along with other legal challenges that Trump is facing, are bolstering Trump’s prospects in the primary election, but will hurt the former president when he goes up against the Democratic nominee in the general election.
“I think that independent voters will look at some of these charges and say, gee, you know, where there’s smoke, there’s fire, but of course, where there’s smoke, sometimes there’s arson. And I think a lot of these fires have been set politically, in order to get Trump,” Dershowitz said, echoing the name of his book, “Get Trump,” in which he argues that Trump’s political enemies have been targeting Trump in a politically motivated campaign.
Reuters contributed to this report. Cross-posted from our premium news partners at The Epoch Times.
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.